A pilot study to understand and respond to loss, theft, and misplacement of hepatitis C treatment medication for people who inject drugs.
| Autor: | Morris MD; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA., McDonell C; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA., Kim RG; Division of Gastroenterology and Hepatology, Department of Medicine, University of Utah, Salt Lake City, Utah, USA., Laguardia Y; Division of Gastroenterology and Hepatology, Department of Medicine, University of California San Francisco, San Francisco, California, USA.; Liver Center, Department of Medicine, University of California San Francisco, San Francisco, California, USA., Kanner R; Division of Gastroenterology and Hepatology, Department of Medicine, University of California San Francisco, San Francisco, California, USA.; Liver Center, Department of Medicine, University of California San Francisco, San Francisco, California, USA., Price JC; Division of Gastroenterology and Hepatology, Department of Medicine, University of California San Francisco, San Francisco, California, USA.; Liver Center, Department of Medicine, University of California San Francisco, San Francisco, California, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Clinical liver disease [Clin Liver Dis (Hoboken)] 2023 May 16; Vol. 22 (3), pp. 81-84. Date of Electronic Publication: 2023 May 16 (Print Publication: 2023). |
| DOI: | 10.1097/CLD.0000000000000042 |
| Abstrakt: | 1_som2wbs2Kaltura. Competing Interests: Meghan D. Morris received grants from Gilead Sciences. Rebecca G. Kim owns stock in and is an employee of Guardant Health. Jennifer C. Price received grants from Gilead Sciences, Merck, Abbvie, and Zydus Therapeutics. The remaining authors have no conflicts to report. (Copyright © 2023 American Association for the Study of Liver Diseases.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|